Cromos Pharma

Name: Cromos Pharma
Address: US Bancorp Tower, 111 S. W. Fifth Avenue, Suite 3150, Portland, OR, 97204, US
Telephone: +15034443463

Call Directions Website

Cromos Pharma is an international research organization (CRO) specializing in clinical trials. Find out more by visiting www.cromospharma.com.

Established in 2004, Cromos Pharma provides tailored and effective clinical trial services to support the development of drugs that transform healthcare. It is an international CRO with over 15 years' experience in offering fully integrated services and delivering all aspects of clinical trials in all clinical phases and a range of therapeutic areas. Cromos Pharma delivers rapid recruitment and excellent patient retention as well as expert study design and management. Cromos Pharma has strong regional experience in Central and Eastern Europe. Its US base is in Portland, Oregon with additional operations in South Florida and its European HQ is situated in Dublin, Ireland.

10/28/2026

What makes Italy a strategic destination for clinical trials in 2026?

With its strong research infrastructure, experienced investigators, and evolving regulatory landscape, Italy offers valuable opportunities for international clinical development.

In our latest article, we explore:

-Key clinical trial trends and patient recruitment opportunities
-AIFA, CTIS, and the latest regulatory updates
-The FAST-EU initiative and accelerated approvals
-Practical considerations for site selection and study start-up

As an AIFA-certified CRO, Cromos Pharma helps sponsors navigate local regulatory requirements and successfully execute clinical trials in Italy.

Read more: https://cromospharma.com/clinical-trials-in-italy-a-2026-guide-to-patient-recruitment-regulatory-approval-and-study-start-up/

10/26/2026

Greetings from ESMO Congress 2026 in Madrid!

Cromos Pharma's CEO, Vlad Bogin, MD, FACP, and our Head of Therapeutic Strategy and Proposals, Andrey Nedosekin, are attending one of the world's leading oncology conferences, connecting with industry leaders, researchers, and biotech innovators.

ESMO is a great opportunity to explore the latest advances in oncology, exchange insights on emerging therapies, and strengthen relationships across the global clinical research community.

We're excited to be part of these important conversations and look forward to the new connections and opportunities ahead!

10/21/2026

Six months ago, we introduced our AI-powered Clinical Trial Budget Calculator. Today, we're seeing the value it brings to clinical trial planning.

Since its launch, we've continued to receive positive feedback from users who appreciate how much time the tool saves and how easily it turns complex budget planning into clear, actionable estimates.

What makes it particularly valuable is its flexibility. Sponsors can explore different study scenarios, adjust countries, clinical phases, site numbers, enrollment targets, and timelines, and receive realistic preliminary cost estimates in minutes.

These estimates provide a practical starting point for internal discussions, help teams compare options, and support more informed decisions before moving into detailed budgeting.

- No lengthy calculations.
- No unnecessary complexity.
- Just a faster, more transparent way to approach early-stage clinical trial budgeting.

Six months on, we're pleased to see the calculator delivering on its original purpose: making clinical trial cost planning more accessible, flexible, and efficient.

Haven't tried it yet? Explore our free AI-powered Clinical Trial Budget Calculator: https://cromospharma.com/expertise/calculator/

10/19/2026

AI can support clinical trial decisions. But who is accountable when something goes wrong?

As AI becomes increasingly integrated into clinical research, questions around validation, human oversight, risk management, and accountability are more important than ever.

We asked Joris De Maeseneire, Head of Quality at Cromos Pharma, six key questions about AI governance, evolving FDA and EMA expectations, and what it takes to ensure responsible AI use in clinical trials.

The key takeaway? You can delegate the task. You cannot delegate the accountability.

Read the full interview: https://cromospharma.com/ai-quality-and-accountability-six-questions-every-quality-leader-should-ask/

10/15/2026

Cromos Pharma is currently seeking an In-house Clinical Research Associate (CRA) to join our team.

Location: Europe

For additional details about this opportunity, please visit our website: https://cromospharma.com/in-house-cra/

If you're ready to apply, please send your CV to [email protected]

10/13/2026

We are pleased to share that Vlad Bogin, MD, FACP, CEO of Cromos Pharma, will be attending ESMO Congress 2026, taking place from October 23 to 27 in Madrid, Spain.

As one of the world’s leading oncology events, ESMO brings together the global oncology community to share the latest advances in cancer research, treatment, and clinical development. Vlad looks forward to connecting with industry leaders and discussing how Cromos Pharma’s oncology expertise and tailored clinical trial solutions can support sponsors in advancing their development programs.

To connect with Vlad during ESMO 2026 or to learn more about how Cromos Pharma can support your oncology clinical development needs, contact us at [email protected].

10/08/2026

Biopharma innovation is accelerating. But is clinical development keeping pace?

From rising R&D costs and longer development timelines to the growing role of emerging biotech and AI, the pharmaceutical industry is facing a new set of challenges.

In our latest article, we explore 7 key numbers shaping biopharma R&D in 2026 and what they mean for sponsors navigating an increasingly complex clinical development landscape.

Discover the trends behind the numbers and why clinical ex*****on is becoming just as critical as scientific innovation.

Read the full article: https://cromospharma.com/state-of-biopharma-r-d-2026-7-numbers-every-sponsor-should-know/

10/06/2026

In the latest edition of Cromos Pharma’s Newsletter, we highlight key developments shaping clinical research and healthcare innovation:

- Replimune secures accelerated FDA approval for Tudriqev after two previous rejections.
- A gene-edited pig kidney keeps a patient off dialysis for a record 271 days.
- Beacon Therapeutics reports positive results from the first successful pivotal gene therapy trial for X-linked retinitis pigmentosa.

Read the full Newsletter: https://cromospharma.com/clinical-research-focus-57th-edition/

10/02/2026

Cromos Pharma is currently seeking a Head of Project Management to join our team.

Location: Europe or USA

For additional details about this opportunity, please visit our website: https://lnkd.in/e3dJPvvP

If you're ready to apply, please send your CV to [email protected]

09/30/2026

New Patient Education Videos Are Now Available

We’ve added new videos to our patient education library, answering some of the most common questions patients may have before and during clinical trial participation.

- Who can see your medical data in a clinical trial?
- Does a placebo always mean no treatment?
- Can you leave a clinical trial after joining?
- What support may be available for patients and their families?
- What does a typical day in a clinical trial look like?

Our short videos explain these topics in clear, simple language, helping patients and their families better understand what clinical trial participation involves.

Watch the latest videos here: https://cromospharma.com/patients-portal/explainer-videos-for-patients/

Patient education is only one piece of the puzzle. Through our AV Department, Cromos Pharma also develops study-specific explainer videos, patient-facing websites, and digital recruitment campaigns that have supported enrollment efforts across oncology, rare disease, CNS, cardiovascular, and other therapeutic areas.

Better-informed patients. Better engagement. Better recruitment.

Address

US Bancorp Tower, 111 S. W. Fifth Avenue, Suite 3150
Portland, OR
97204

Telephone

+15034443463

Website

http://www.cromospharma.com/

Alerts

Be the first to know and let us send you an email when Cromos Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.